Medication info
Risemec Tablet 35 mg (Risedronate Sodium 2.5 Hydrate)

Risemec Tablet 35 mg (Risedronate Sodium 2.5 Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.17mg / 1 tablet
Manufacturer / importer
Korea United Pharmaceutical Co., Ltd.
Appearance
Pale orange rectangular film-coated tablet
Packaging
4 tablets/PTP (4 tablets/PTP X 1)
Approval status
Active

MFDS item code 200713911 · Notified 2007.12.31 · Insurance code 644306200

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
1. Adults : Administer 35 mg of risedronate sodium orally once weekly. 2. Older adults : No dosage adjustment is necessary in older adults (over 60 years of age), since the bioavailability and pharmacodynamics of this drug are similar to those in younger people. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or greater. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance below 30 mL/min. ○ Food interferes with the absorption of this drug. To ensure adequate absorption, take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To help this drug reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce absorption of this drug. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take a dose on the scheduled dosing day, take it the next morning when remembered. Take the next dose on the originally scheduled dosing day. Do not take 2 tablets on the same day.
Child dose
3. Children : The safety and efficacy in children under 18 years of age have not been established.

Ingredients

Manufacturer
Korea United Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This medication is used to treat and prevent osteoporosis in postmenopausal women and men.

How to take

Adult dose

1. Adults : Administer 35 mg of risedronate sodium orally once weekly. 2. Older adults : No dosage adjustment is necessary in older adults (over 60 years of age), since the bioavailability and pharmacodynamics of this drug are similar to those in younger people. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or greater. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance below 30 mL/min. ○ Food interferes with the absorption of this drug. To ensure adequate absorption, take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To help this drug reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce absorption of this drug. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take a dose on the scheduled dosing day, take it the next morning when remembered. Take the next dose on the originally scheduled dosing day. Do not take 2 tablets on the same day.

Child dose

3. Children : The safety and efficacy in children under 18 years of age have not been established.

Precautions

This medication can irritate the gastric mucosa, so caution is needed for those with upper gastrointestinal diseases such as gastritis, esophageal disease, and ulcers. If symptoms such as difficulty swallowing, chest pain, or heartburn occur during use, stop taking the medication immediately and consult a physician. It is important to take it with a sufficient amount of water and to avoid lying down for at least 30 minutes after taking it. Particularly, continued use after experiencing esophageal irritation could lead to serious side effects, so care should be taken. Patients with esophageal motility disorders, hypocalcemia, severe renal impairment, pregnant or potentially pregnant women, and nursing mothers should not take this medication. Those with genetic issues such as lactose intolerance should also avoid taking it. This medication is used for the treatment of osteoporosis, and it is advisable to take it along with calcium and vitamin D. Rarely, serious side effects such as jaw osteonecrosis and atypical femur fractures have been reported with long-term use, so consult a physician immediately if unusual symptoms occur. This medication may interact with other drugs, so inform your physician of any medications currently being taken. Avoid using it during pregnancy or breastfeeding, and consult a specialist if necessary. The safety of this medication for children under the age of 18 has not been established, and it can be used by the elderly without special dosage adjustments. In case of overdose, blood calcium and phosphate levels may decrease, so visit a medical institution immediately for appropriate treatment. Store this medication out of the reach of children and do not transfer it to another container.

Side effects

  • Esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • bleeding
  • infection
  • back pain
  • accidental injury
  • pain
Show 57 more
  • abdominal pain
  • flu symptoms
  • headache
  • weakness
  • throat pain
  • chest pain
  • allergic reaction
  • hypertension
  • constipation
  • diarrhea
  • dyspepsia
  • nausea
  • peripheral edema
  • arthralgia
  • arthritis
  • fracture
  • joint abnormalities
  • myalgia
  • bone pain
  • dizziness
  • depression
  • insomnia
  • bronchitis
  • sinusitis
  • rhinitis
  • pharyngitis
  • increased cough
  • rash
  • cataract
  • urinary tract infection
  • vomiting
  • uveitis
  • scleritis
  • iritis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • Riel syndrome
  • angioedema
  • blister
  • skin reaction
  • jaw necrosis
  • liver dysfunction
  • jaundice
  • loss of appetite
  • asthenia
  • heartburn
  • epigastric pain
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • eye pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture. It should be kept at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale orange rectangular film-coated tablet

Package unit

4 tablets/PTP (4 tablets/PTP X 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.